iodine I 125

RADIATION6 trials

Sponsors

Radiation Therapy Oncology Group, New Approaches to Brain Tumor Therapy Consortium, Barrett Cancer Center, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology

Conditions

Brain and Central Nervous System TumorsLung CancerProstate Cancer

Phase 1

Brachytherapy in Treating Patients With Recurrent Malignant Glioma

CompletedNCT00045474

National Cancer Institute (NCI)Brain and Central Nervous System Tumors

Start: 2002-10-31Updated: 2009-02-09

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

CompletedNCT00003876

Barrett Cancer CenterBrain and Central Nervous System Tumors

Start: 1999-04-30End: 2004-05-31Updated: 2013-06-26

Phase 2

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

CompletedNCT00006365

Radiation Therapy Oncology GroupProstate Cancer

Start: 2000-11-30End: 2013-11-30Updated: 2020-10-22

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

CompletedNCT00003574

New Approaches to Brain Tumor Therapy ConsortiumBrain and Central Nervous System Tumors

Start: 1999-04-30End: 2004-06-30Updated: 2013-06-21

Brachytherapy in Treating Patients With Prostate Cancer

CompletedNCT00003312

Radiation Therapy Oncology GroupProstate Cancer

Start: 1998-09-30End: 2013-11-30Target: 95Updated: 2014-01-24

Phase 3

Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

TerminatedNCT01336894

Alliance for Clinical Trials in OncologyLung Cancer

Start: 2011-05-31End: 2017-03-27Updated: 2017-05-30

Related Papers

Protocol for the Veterans Affairs Cooperative Studies Program Study Number 2005

CHEST Pulmonary2023-10-057 citations

The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

Pilot and Feasibility Studies2016-01-2744 citations